DIFFERENCES OF INTERLEUKIN-18 AND INTERLEUKIN-10 LEVELS IN RIFAMPICIN RESISTANT AND RIFAMPICIN SENSITIVE PULMONARY TUBERCULOSIS PATIENTS IN DR. SOETOMO HOSPITAL SURABAYA
Downloads
Rifampicin is an anti-tuberculosis drug which has an efficient antimicrobial effect and the basis of a short-term treatment regimen for tuberculosis (TB) patients. Rifampicin plays an important role against the growth and slow metabolism of Bacilli M. tuberculosis. Resistance to rifampicin causes the duration of tuberculosis treatment to be longer. Interleukin-18 (IL-18) is a pro-inflammatory cytokine which plays a role in controlling the growth of M. tuberculosis through its ability to induce IFN-γ, while Interleukin-10 (IL-10) is an anti-inflammatory cytokine which plays a role in limiting tissue damage due to the inflammatory process and maintain tissue homeostasis. IL-18 and IL-10 has an important role in explaining the different degrees of inflammation in rifampicin resistant (RR) and rifampicin sensitive (RS) pulmonary tuberculosis patients. The purpose of this study is to determine different levels of IL-18 and IL-10 in new TB patients with RR and RS. This study was a retrospective cohort study with a cross-sectional design carried out from August-November 2018 in the TB-DOTS/MDR clinic at Dr. Soetomo Hospital, Surabaya. 50 research subjects were examined and grouped into two groups, namely pulmonary TB with RR (n = 25) and pulmonary TB with RS (n = 25) based on GeneXpert examination and anti-tuberculosis drug therapy ≤ 1 month. IL-18 and IL-10 were measured using the ELISA Method. Differences in IL-18 and IL-10 levels between groups were analyzed using the Mann-Whitney test. The mean level of IL-18 (pg/ml) in RR and RS pulmonary TB patients were 1273.53±749.86 and 787.96 ±589.28 respectively. The mean level of IL-10 (pg/ml) in RR and RS pulmonary TB patients were 125.25±118.32 and 128.81±135.77 repectively. The mean level of IL-18 in RR and RS pulmonary TB patients were found to have a significant difference, while the mean level of IL-10 did not have a significant difference.
Keywords: Interleukin-18, Interleukin-10, Tuberculosis, Rifampicin Resistant, Rifampicin Sensitive
WHO. Global Tuberculosis Report 2017. World Health Organization. 2017
Kemenkes RI. Pedoman Nasional Pengendalian Tuberkulosis. Jakarta: Kemenkes RI. 2014
Dasilva P, Palomino J. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of Antimicrobial Chemotherapy; 2011. Volume 66, Issue 7, 1417-1430.
Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin induced serum factor that stimulates gamma interferon production. Infection Immunology; 1989. Vol 57. 590-595.
Dinarello C, Novick D, Kim S, Kalplanski G. Interleukin-18 and IL-18 binding protein. Frontiers of Immunology; 2013. Vol.4:289
Yamada G, Shijubo N, Shigera K, Okamura H, Kuromoto M, Abe S. Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis. American Journal of Respiratory and Critical Care Medicine; 2000. Vol. 161. 1786-1789.
Iyer SS, Cheng G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease. Critical Reviews in Immunology; 2012. Vol. 32(1), 23-63.
Ng TH, Britton GJ, Hili EV, Verhagen J, Burton BR, Wrauth DC. Regulation of adaptive immunity; the role of interleukin-10. Frontiers in Immunology; 2013. Vol. 4.
Abdalla AE, Lambert N, Duan X, Xie J. Interleukin-10 Family and Tuberculosis : An Old Story Renewed. International Journal of Biological Sciences; 2016. Vol. 12(6), 710-717.
Gamal A, El-Gazzar A. Circulating Il-18 and Osteopontin in Pulmonary Tuberculosis Patients and Their Correlation with Disease Activity. Egyptian Journal of Medical Microbiology; July 2008.
Herawati S, Nugraha J. Paras Il-18 Penderita TB Paru dan Perawat Sehat Beresiko Tuberkulosis. Indonesian Journal of Clinical Pathology and Medical Laboratory; 2008. Vol. 14
Wang Y, Chunmei H, Zailang W, Hui K, Weiping X, Hong W. Serum IL-1β and IL-18 Correlate with ESR and CRP in Multi-drug Resistant Tuberculosis Patients. Journal of Biomedical research; 2015. Vol. 29(5). 426-428.
Lim YJ, Yi MH, Choi JA, Lee J, Han JY, Jo SH, Oh SM, Cho HJ, Kim DW, Kang MW, Song CH. Roles of endoplasmic reticulum stress-mediated apoptosis in M1-polarized macrophages during mycobacterial infections. Scientific Reports; 2016. Vol. 6
Wang S, Zhang J, Sui L, Xu H, Piao Q, Qu X, Sun Y, Song L, Li D, Peng L, Hua S, Hu G, Chen J. Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis. Scientific Reports; 2017. Volume 7
Barnes P, Wizel B. Type 1 Cytokines and The Pathogenesis of Tuberculous. American Journal of Respiratory and Clinical Care Medicine; 2000. Volume 161(6).
Redford P, Murray J, O'Garra A. The Role of IL-10 in Immune Regulation during M. tuberculosis Infection. Mucosal Immunology; 2011. Vol. 4(3).
Peñaloza, H. F., Schultz, B. M., Nieto, P. A., Salazar, G. A., Suazo, I., Gonzalez, P. A., et al. Opposing roles of IL-10 in acute bacterial infection. Cytokine Growth Factor Reviews; 2016. Vol. 32. 17–30
Butov DO, Mykhalio K, Kuzhko BT. Interleukin-10 Gene Polymorphisms is Associated with Multi-drug resistance Tuberculosis in Ukranian Population. International Journal of Mycobacteriology; 2016.
Lihawa N, Yudhawati R. Hubungan Kadar IL-10 dan Tuberculosis Multi-drug Resistant. Jurnal Respirasi; 2015. Vol 1(2).
Penaloza H, Noguera L, Riedel C, Bueno S. Expanding the Current Knowledge About the Role of Interleukin-10 to Major Concerning Bacteria. Frontiers in Microbiology, 2018.
Copyright (c) 2020 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
